Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
165.5 USD | -1.32% | +4.51% | -7.95% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.95% | 9.25B | |
-4.66% | 183B | |
-1.01% | 108B | |
-4.20% | 67.51B | |
+2.68% | 50.67B | |
+9.12% | 44.7B | |
+3.46% | 40.95B | |
+4.13% | 26.71B | |
+3.31% | 26.8B | |
+13.57% | 24.62B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Sector Update: Health Care Stocks Flat to Lower Premarket Wednesday